Evidence-Based Pediatric Oncology (eBook)
296 Seiten
John Wiley & Sons (Verlag)
978-1-118-62517-0 (ISBN)
pediatric oncologists
This groundbreaking text on the management of childhood cancers
covers most tumor types occurring in children and young adults and
provides reviews of randomized trials with commentaries on the
optimum treatments for childhood cancer.
Updated with evidence from the latest published
reviews--and even more clinically focused than previous
editions-- Evidence-Based Pediatric Oncology, Third
Edition places an emphasis on application of the trial
findings. With increased coverage of the area of supportive care
for pediatric cancer patients, each chapter opens with an expert
commentary on the key clinical issues followed by a summary of
trial findings.
Evidence-Based Pediatric Oncology, Third Edition:
* Presents evidence for the best treatment of children and
adolescents with cancer
* Includes commentaries from the world's leading
experts for every topic discussed
* Is internationally relevant thanks to contributions from
the UK, US, Canada and Australia
* Places greater emphasis on supportive care and features
a new extended section on antibiotic and antifungal treatments
Based on information gathered from randomized trials performed
after the release of the Second Edition, readers will find
Evidence-Based Pediatric Oncology to be an important
resource for all those treating young people with cancer.
Edited by Ross Pinkerton, MB, BCh, BaO, MD, Executive Director, Division of Oncology, Royal Children's Hospital, Children's Health Queensland, Brisbane, QLD, Australia Ananth Shankar, MD, FRCPCH, Consultant in Paediatric and Adolescent Oncology, University College London Hospitals NHS Foundation Trust, London, UK Katherine K. Matthay, BA, MD, Mildred V. Strouss Professor of Translational Oncology, Director, Pediatric Hematology-Oncology, Department of Pediatrics, UCSF School of Medicine and UCSF Benioff Children's Hospital, San Francisco, CA, USA
List of contributors, vii
Preface, ix
List of abbreviations, x
About the companion website, xv
Part 1: Solid tumors
1 Rhabdomyosarcoma, 3
Katherine K. Matthay
(Commentary by Meriel Jenney)
2 Osteosarcoma, 14
Katherine K. Matthay
(Commentary by Maria Michelagnoli)
3 Ewing sarcoma, 25
Katherine K. Matthay
(Commentary by Steven G. DuBois)
4 Wilms tumor, 34
Ananth Shankar
(Commentary by Kathy Pritchard-Jones)
5 Neuroblastoma, 47
Katherine K. Matthay
(Commentary by Katherine K. Matthay)
6 Hepatoblastoma, 58
Ross Pinkerton
(Commentary by Penelope Brock)
7 Malignant germ cell tumors, 65
Ross Pinkerton
(Commentary by Ross Pinkerton)
8 Medulloblastoma, 69
Ross Pinkerton
(Commentary by Eric Bouffet)
9 Glioma, 81
Ross Pinkerton
(Commentary by Joann L. Ater)
10 Non-Hodgkin lymphoma, 88
Ross Pinkerton
(Commentary by Ross Pinkerton)
11 Hodgkin lymphoma, 105
Ross Pinkerton
(Commentary by Cindy L. Schwartz)
Part 2: Leukemia
Section 1: Acute myeloid leukemia 12 Acute myeloid leukemia commentary, 119
Robert J. Arceci
13 Remission induction in acute myeloid leukemia, 126
Ananth Shankar
14 Acute myeloid leukemia consolidation, 135
Ananth Shankar
15 Maintenance treatment in acute myeloid leukemia, 137
Ananth Shankar
16 Autologous bone marrow transplantation in acute myeloid leukemia, 141
Ananth Shankar
17 Acute myeloid leukemia: miscellaneous, 144
Ananth Shankar
Section 2: Childhood lymphoblastic leukemia
18 Childhood lymphoblastic leukemia commentary, 146
Vaskar Saha
19 Remission induction in childhood lymphoblastic leukemia, 154
Ananth Shankar
20 Central nervous system-directed therapy in childhood lymphoblastic leukemia, 168
Ananth Shankar
21 Maintenance treatment in childhood lymphoblastic leukemia, 180
Ananth Shankar
22 Relapsed childhood lymphoblastic leukemia, 198
Ananth Shankar
23 Postinduction therapy in adolescents and young adults with acute lymphoblastic leukemia, 204
Ananth Shankar
Part 3: Supportive care in pediatric oncology
24 Colony-stimulating factors, 209
Ananth Shankar
(Commentary by Victoria Grandage)
25 Cardioprotection in pediatric oncology, 230
Ananth Shankar
(Commentary by Gill A. Levitt)
26 Infections in pediatric and adolescent oncology, 243
Ananth Shankar and Sara Stoneham
(Commentary by Julia E. Clark)
Index, 269
| Erscheint lt. Verlag | 19.2.2013 |
|---|---|
| Reihe/Serie | Evidence-Based Medicine | Evidence-Based Medicine |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pädiatrie | |
| Schlagworte | Evidence-based Health Care • Evidenzbasierte Forschung im Gesundheitswesen • Evidenzbasierte Medizin • Medical Science • Medizin • Pädiatrische Onkologie • Pädiatrische Onkologie |
| ISBN-10 | 1-118-62517-X / 111862517X |
| ISBN-13 | 978-1-118-62517-0 / 9781118625170 |
| Haben Sie eine Frage zum Produkt? |
EPUB (Adobe DRM)Größe: 817 KB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
